Long-Term Survival and Apolipoprotein A1 Level in Chronic Heart Failure: Interaction With Tumor Necrosis Factor α −308 G/A Polymorphism
- 1 February 2017
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (2) , 113-120
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Heart Failure is Associated With Impaired Anti-Inflammatory and Antioxidant Properties of High-Density LipoproteinsThe American Journal of Cardiology, 2013
- Cardiac Metabolism in Heart FailureCirculation Research, 2013
- Predictors of Fatal and Non-Fatal Outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): Incremental Value of Apolipoprotein A-1, High-Sensitivity C-Reactive Peptide and N-terminal pro B-type Natriuretic PeptideEuropean Journal of Heart Failure, 2009
- Potential Autonomic Nervous System Effects of Statins in Heart FailureHeart Failure Clinics, 2008
- Association of Low Serum Levels of Apolipoprotein A-I With Adverse Outcomes in Patients With Nonischemic Heart FailureJournal of Cardiac Failure, 2007
- Tumor Necrosis Factor α Polymorphism in Heart Failure/CardiomyopathyCongestive Heart Failure, 2004
- Association Between the TNF-2 Allele and a Better Survival in Cardiogenic ShockChest, 2004
- Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytesBlood, 2001
- Polymorphisms of Tumor Necrosis Factor-.ALPHA. and Interleukin-10 Genes in Japanese Patients with Idiopathic Dilated Cardiomyopathy.Japanese Heart Journal, 2000
- Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to diseaseJournal of Leukocyte Biology, 1999